APA (7th ed.) Citation

Façon, T., Dimopoulos, M., Leleu, X. P., Beksac, M., Pour, L., Hâjek, R., . . . Goldschmidt, H. (2024). Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. New England Journal of Medicine, 391(17), 1597. https://doi.org/10.1056/NEJMoa2400712

Chicago Style (17th ed.) Citation

Façon, Thierry, et al. "Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma." New England Journal of Medicine 391, no. 17 (2024): 1597. https://doi.org/10.1056/NEJMoa2400712.

MLA (9th ed.) Citation

Façon, Thierry, et al. "Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma." New England Journal of Medicine, vol. 391, no. 17, 2024, p. 1597, https://doi.org/10.1056/NEJMoa2400712.